Respirology

CPAP reduces need for 30-day intubation in COVID patients, but not mortality 'unsettling' study finds
Researchers suggests CPAP should be the initial treatment of choice in patients not yet needing intubation.
It may be possible for people who got Omicron to be reinfected with it, experts say
As many as four million Ontarians may have been infected with the Omicron variant, according to the province's science advisers, but their illnesses—particularly the milder ones—may not stop them from getting reinfected.

Study: more dialysis patients saw strong antibody response with Moderna vaccine
Pop quiz: Paxlovid drug interactions

All of the following medications are contraindicated concomitantly with Paxlovid (nirmatrelvir/ritonavir), EXCEPT for . . .
Study: Those with disabilities had longer COVID hospital stays, high readmission rate

Sandi Bell knows how difficult it can be for someone with a disability to book a vaccine appointment through an online portal, or feel confident they'll have a ride home from the clinic afterwards.
How do patients fare one year after intensive care unit treatment for COVID-19?

Study finds physical, mental and cognitive symptoms are frequent in survivors one year after ICU treatment for COVID-19.
Resource on nirmatrelvir/ritonavir for prescribers and pharmacists

The Ontario COVID-19 Science Advisory Table and the University of Waterloo's School of Pharmacy have put together a resource for prescribers and pharmacists on Nirmatrelvir/Ritonavir (Paxlovid) and its use in treating COVID-19.
Solving the puzzle of cystic fibrosis and its treatments is a Nobel Prize-worthy breakthrough

The nomination deadline for the Nobel Prize in physiology or medicine is fast approaching. Besides those for the COVID-19 vaccines, several others are prominent, including the discovery of the cystic fibrosis gene and the drugs to treat the disease.
COVID-19 diagnosis leads to decline in mobility and functioning in older adults

Canadian study shows non-hospitalized adults age 50+ with COVID-19 have higher risk of worsening mobility and physical function compared with those without COVID-19.
Canadian trial: remdesivir reduces need for ventilation by half for COVID patients

The study, published Wednesday in the Canadian Medical Association Journal, is the largest single-country trial of remdesivir reported to date.

CPAP reduces need for 30-day intubation in COVID patients, but not mortality 'unsettling' study finds

It may be possible for people who got Omicron to be reinfected with it, experts say

Study: more dialysis patients saw strong antibody response with Moderna vaccine

Pop quiz: Paxlovid drug interactions

Study: Those with disabilities had longer COVID hospital stays, high readmission rate

How do patients fare one year after intensive care unit treatment for COVID-19?

Resource on nirmatrelvir/ritonavir for prescribers and pharmacists

Solving the puzzle of cystic fibrosis and its treatments is a Nobel Prize-worthy breakthrough

COVID-19 diagnosis leads to decline in mobility and functioning in older adults

Canadian trial: remdesivir reduces need for ventilation by half for COVID patients